Mainz Biomed Ratios (2020-2025) | MYNZ

Ratios Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Jun2024 Dec2024 Jun2025
Profitability
Gross Margin 46.17%58.04%19.23%18.78%55.55%59.77%47.99%62.74%
EBT Margin -5,631.92%-4,983.27%-5,781.76%-4,236.66%-2,623.28%-3,314.68%-3,467.71%-2,413.53%
EBIT Margin -5,599.92%-4,989.88%-5,657.13%-4,340.30%-2,593.94%-3,183.87%-3,104.90%-3,068.71%
EBITDA Margin 5,595.68%4,950.09%5,715.54%-4,340.30%2,647.49%3,350.84%3,202.69%-22,155.68%
Operating Margin -5,599.92%-4,989.88%-5,657.13%-4,340.30%-2,593.94%-3,183.87%-3,104.90%-3,068.71%
Net Margin -5,631.92%-4,983.27%-5,781.76%-4,236.66%-2,623.28%-3,314.68%-3,467.71%-2,413.53%
FCF Margin -2,667.18%-2,529.60%-3,315.54%-3,111.77%-1,902.59%-2,006.51%-3,574.11%-3,208.71%
Efficiency
Inventory Average 0.04M-0.15M
Assets Average 5.36M19.89M19.42M18.61M16.66M11.93M10.85M11.52M
Equity Average 1.81M
Invested Capital -2.68M6.44M0.07M14.17M0.03M0.03M0.03M8.11M0.03M7.07M
Asset Utilization Ratio 0.030.040.050.050.050.040.02
Leverage & Solvency
Debt to Equity -0.010.210.001.500.17
Debt Ratio 0.040.130.000.000.000.000.000.320.000.08
Equity Ratio -4.070.630.700.210.46
Valuation
Enterprise Value -0.12M-8.73M-8.73M-8.73M-8.73M-17.14M-17.14M-17.14M-9.32M-7.07M-0.98M-6.24M-1.91M
Return Ratios
Return on Sales -56.32%-49.83%-57.82%-42.37%-26.23%-33.15%-34.68%-24.14%-30.58%-28.97%-24.14%
Return on Capital Employed -2.07%-3.25%-3.87%-3.59%
Return on Assets -1.37%-1.47%-1.57%-1.58%-1.65%-1.06%-0.45%